Mubasher is one of the founders of Celixir.
He became a partner in Permira in 2015 and is Head of the Healthcare Sector Team having worked on a number of transactions including Mesa and Asteral.
Prior to joining Permira, Mubasher spent 11 years at McKinsey & Co, including six as Partner, playing multiple roles including Head of the Global Pharmaceutical R&D, the European Healthcare Private Equity and the Principal Investing Industry practices. As a Partner at McKinsey, Mubasher managed a client portfolio ranging from start-ups to top tier pharmaceutical companies, including over half of the world’s leading pharmaceutical, biotech and medical devices companies. He has undertaken over 80 projects and advised Boards on strategy and improvement issues with a particular emphasis on improving growth, M&A and technology.
He originally qualified as a doctor and spent five years as a transplant physician and lecturer at teaching hospitals in London and Cambridge.
Mubasher holds both a degree and post graduate degree in Medicine from the University of London and the Royal College of Physicians, England and has a deep healthcare sector knowledge.